Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Receivables - Other (2021 - 2022)

Edesa Biotech's Receivables - Other history spans 3 years, with the latest figure at $1.1 million for Q2 2022.

  • For Q2 2022, Receivables - Other fell 72.44% year-over-year to $1.1 million; the TTM value through Jun 2022 reached $1.1 million, down 72.44%, while the annual FY2021 figure was $3.0 million, N/A changed from the prior year.
  • Receivables - Other for Q2 2022 was $1.1 million at Edesa Biotech, roughly flat from $1.1 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $4.0 million in Q2 2021 and bottomed at $1.1 million in Q1 2022.